Drug Discovery

#Biopharma #Biotechnology #CDMO #Drug development

Why project management holds the key to efficient drug development

Listen to this article on the DDW Podcast: Ian Hollingsworth, Associate Director of product development at Boyds, the global drug development consultancy, explains the benefits to the drug development lifecycle of building strong partnerships with external consultants, and when and how to get the best from them. Everyone can… Read More

#Exclusive Content

#DNA #Drug discovery #Gene sequencing #Synthetic biology

A different approach: reimagining biology

Listen to this article on the DDW Podcast: Evonetix is reimaging biology by developing a different approach to gene synthesis. Three key members of the team – Dr Raquel Sanches-Kuiper, Vice President of Technology, Dr Matthew Hayes, Chief Technology Officer and John Edgell, Head of Cloud Engineering… Read More

#Exclusive Content

#Drug delivery #Drug development #Formulation

Streamlining development with containment in early drug discovery

Gurmeet Singh, Senior Director at West Pharmaceutical Services & Jeff Kyle, Senior Director of Wearable Delivery Systems explore how a focus on containment in early drug discovery can help ease the development process later on. It may seem counterintuitive to spend time and money on planning for containment… Read More

#Exclusive Content

#Drug discovery #Neurology #Small molecules

Sosei teams up with Abbvie on neurological drug discovery  

Biopharmaceutical group Sosei will work together with AbbVie on a drug discovery project to discover, develop and commercialise small molecules that target neurological diseases.   The agreement will see the companies combining their expertise and capabilities in neuroscience to discover and develop small molecules that modulate G protein-coupled… Read More

#News

#Drug development #Regulatory

Addressing the developability gap in pharma

Listen to this article on the DDW Podcast: Susan A Darling, Senior Director, CE and Biopharma, SCIEX and Todd Stawicki, Senior Global Marketing Manager, Biopharma, SCIEX examine advanced analytical technologies can help ensure that biopharma candidates are commercialisable. Developability in the biopharmaceutical industry relates to the difficulty… Read More

#Exclusive Content

Human brain
#Biologics / Biotechnology #Clinical trials #Drug discovery #Neurology

Calidi Biotherapeutics gets FDA go-ahead for US trial  

Biotechnology company Calidi Biotherapeutics has announced that a Phase I US clinical trial will use the company’s licensed oncolytic virotherapy platform NeuroNova to deliver an oncolytic adenovirus selectively to tumor sites in patients with recurrent high-grade glioma.  The phase I physician-sponsored clinical trial will take place at… Read More

#News

#AI / data analytics / healthtech / informatics #Automation / robotics #Drug discovery #ELRIG

DDW supports ELRIG at Drug Discovery 2022 

For the first time, a series of short seminars focused on automation will be available to visitors of Drug Discovery 2022 (4-5 Oct, London, UK).   The seminars will be held in a dedicated Tech Theatre, centrally located in the exhibition hall. DDW has been selected by ELRIG… Read More

#News

#Autoimmune disease #Diabetes #Drug discovery

Australian discovery boosts hopes of preventing Type 1 diabetes

Australian researchers based may be a step closer to preventing Type 1 diabetes after identifying a crucial protein that could prevent the autoimmune disease from taking hold. Mater Research and University of Queensland researchers have developed a biological agent, sRAGE, that boosts white blood cell function which is damaged in… Read More

#Editor's Choice #News #Trending News

Clinical trial
#Clinical trials #Drug development #Podcast

Latest DDW Podcast: Transforming clinical trials

This is the latest episode of the free DDW podcast, “Now is the time for the transformation of clinical trials”. It covers two narrated articles written for Volume 22, Issue 4 – Fall 2021 of DDW. They are called “Clinical trials, the pandemic and technology” and “Pharma and the… Read More

#News

Clinical trial
#Clinical trials #Drug development #Narrated podcasts

Now is the time for the transformation of clinical trials

This is the latest episode of the free narrated DDW podcast, “Now is the time for the transformation of clinical trials”. It covers two narrated articles written for Volume 22, Issue 4 – Fall 2021 of DDW. They are called “Clinical trials, the pandemic and technology” and… Read More

#Podcasts

Team of scientists working in a lab
#Cell and protein analysis #Drug discovery #Mass spectrometry / NMR

Native mass spectrometry: Drug discovery’s new kid on the block

Listen to this article on the DDW Podcast: By Idlir Liko, Kleitos Sokratous & Miguel Silva at OMass Therapeutics Current drug discovery methods have limited success against certain drug targets and better approaches are needed. Professor Dame Carol Robinson’s work, including her recent publication in Nature, highlights… Read More

#Exclusive Content

Psilocybin
#Biologics / Biotechnology #Drug discovery #Psychedelics

How this biotech is ramping up its psychedelic drug discovery

Psychedelic plants and fungi have been used medicinally by indigenous populations over thousands of years. But while psychedelic drug research has witnessed a relative roller-coaster ride of effort since the mid-20th century, more recent interest in the use of psychedelics for treating mental health and psychiatric disorders has spurred… Read More

#Exclusive Content

#Covid-19 #DNA #Drug discovery #Genomics #Infectious diseases

This week in drug discovery (18 -22 July)

News round-up by DDW’s Reece Armstrong for 18 – 22 July Covid-19 vaccines remain effective six months after second dose  Two doses of Covid-19 vaccines were sufficient in providing protection against severe cases of the infectious disease, according to new research.   New combination therapy… Read More

#News

#Drug development #Manufacturing

Altasciences continues manufacturing expansion in the US 

Contract research organisation (CRO) Altasciences is expanding its formulation, manufacturing and analytical services in the US as part of a project with the biopharmaceutical company Alladapt Immunotherapeutics.  Altasciences is building dedicated facilities for Alladapt to help with the company’s Phase III and commercial requirements.  … Read More

#News

#Antibodies #Drug discovery #Drug screening

Carterra joins TetraScience Network to boost antibody services  

Life sciences company Carterra has joined data cloud company TetraScience’s network of partners to help generate insights into the potential of antibodies as drug candidates.  The Tetra Partner Network (TPN) is an ecosystem of partners which connects R&D data for pharmaceutical and biopharmaceutical customers.   Carterra… Read More

#News